Tracking a Tactile Signal Along the Nervous System
Launched by VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY · Jan 26, 2024
Trial Information
Current as of December 30, 2024
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Tracking a Tactile Signal Along the Nervous System," is studying how touch signals travel from our fingers through the nervous system to the brain. It aims to understand the journey of these signals in two groups: young adults without any health issues and individuals who have had a stroke. By examining how these touch signals are processed, researchers hope to learn more about tactile perception, which is our ability to feel and interpret touch.
To be eligible for the trial, participants should be right-handed and fall within specific age groups. For the first part of the study, young adults aged 18 to 23 can participate. For the second part, individuals who have had a stroke and those who are neurotypical (without neurological conditions) will be matched in age. Participants can expect to engage in activities that measure how they perceive touch. It's important to note that certain individuals, such as minors, pregnant women, and those with specific medical histories, will not be able to participate. Overall, this trial could provide valuable insights into how our nervous system processes touch, especially for those who have experienced a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -right-hand dominance for participants who are neurotypical
- For Aim 1:
- • -age range of 18-23
- For Aim 2:
- • participants who are neurotypical will be a similar age to the participants with stroke
- • participants who are neurotypical will have no musculoskeletal and neurological conditions
- • participants with stroke will have a single stroke incident resulting in a unilateral lesion (ischemic and hemorrhagic)
- • participants with stroke will be in the chronic phase (\>1 year from stroke onset)
- • participants with stroke will have an onset of stroke after the age of 18
- • participants with stroke who meet the criteria of having the capacity to provide informed consent, regardless of aphasia
- Exclusion Criteria:
- • minors
- • pregnant women
- • prisoners
- • adults not capable of consenting on their own behalf.
- For Aim 2:
- • participants with stroke who have used antispastic injections in the past six months
- • participants with stroke who have a lesion in the brainstem and/or cerebellum
- • participants with stroke who have a stroke arising due to brain surgery
- • participants with stroke who have hemineglect
Trial Officials
Netta Gurari, PhD
Principal Investigator
Virginia Polytechnic Institute and State University
About Virginia Polytechnic Institute And State University
Virginia Polytechnic Institute and State University, commonly known as Virginia Tech, is a leading public research university renowned for its commitment to innovation and excellence in education. With a strong emphasis on interdisciplinary collaboration, Virginia Tech fosters advancements in various fields, including health sciences and engineering. The university actively engages in clinical research to address pressing health challenges, leveraging its state-of-the-art facilities and expert faculty to conduct rigorous clinical trials. Through its initiatives, Virginia Tech aims to enhance patient care and contribute to the scientific community's understanding of diverse health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roanoke, Virginia, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0